<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9819">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01775605</url>
  </required_header>
  <id_info>
    <org_study_id>11-376</org_study_id>
    <nct_id>NCT01775605</nct_id>
  </id_info>
  <brief_title>Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement</brief_title>
  <official_title>Randomized Study of the Use of Synera for Pain Relief During Local Lidocaine Needle Skin Infiltration for Epidural Placement in Subjects Undergoing Elective Cesarean Section.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Shore Long Island Jewish Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Shore Long Island Jewish Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Local infiltration with lidocaine prior to epidural placement for cesarean section, although
      brief, can be painful. This pain can lead to increased anxiety and distress, adversely
      affecting  patient's overall experience. This study proposes to examine the application of
      Synera pain patch prior to lidocaine infiltration to reduce this pain and anxiety.

      The primary objective of this study is to determine the effect of the Synera on maternal
      experience during epidural placement. The efficacy of Synera pain patch in reducing subject
      pain during skin infiltration with lidocaine prior to epidural placement in subjects
      presenting for scheduled cesarean section will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Rating of pain intensity upon lidocaine infiltration</measure>
    <time_frame>30 minutes (following patch placement , upon lidocaine infiltration)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject anxiety</measure>
    <time_frame>1 hour (Upon admission to surgical holding area and  after epidural placement)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">147</enrollment>
  <condition>Pain</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Synera</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Synera Pain Patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No patch control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Synera</intervention_name>
    <description>Synera Pain Patch</description>
    <arm_group_label>Synera</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years old;

          -  Undergoing pre-scheduled cesarean section;

          -  Expected singleton birth;

          -  BMI &lt;=35kg.m-2;

        Exclusion Criteria:

          -  Undergoing emergency cesarean section;

          -  Complications during  pregnancy;

          -  History of hypersensitivity to study medication(lidocaine or tetracaine) or
             para-aminobenzoic acid;

          -  Allergies to bird proteins, feathers, or egg products; or any other skin allergies;
             dermatitis an open wound at the patch site or a history of difficult epidural
             placement;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Strobel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore Long Island Jewish Health System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alan Strobel, MD</last_name>
    <phone>516-562-4887</phone>
    <email>astrobel@nshs.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Shore Unniversity Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alan Strobel, MD</last_name>
      <phone>516-562-4887</phone>
      <email>astrobel@nshs.edu</email>
    </contact>
    <investigator>
      <last_name>Alan Strobel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 27, 2013</lastchanged_date>
  <firstreceived_date>December 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subject</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
